Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction

Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction

Paperback

$13.68 $17.95 Save 24% Current price is $13.68, Original price is $17.95. You Save 24%.
View All Available Formats & Editions
Eligible for FREE SHIPPING
  • Get it by Monday, October 23 , Order now and choose Expedited Delivery during checkout.

Overview

Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction by Ray Moynihan, Barbara Mintzes

Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales, Sex, Lies, and Pharmaceuticals reveals how women’s sexual difficulties are being repackaged as symptoms of a new disorder. In this compelling book, award-winning journalist Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it. The authors go inside the corridors of medical power to visit drug company–sponsored scientific meetings and medical education events where doctors are being trained to see women’s sexual problems as the symptoms of FSD — a pharmaceutically treatable condition. Moynihan and Mintzes explore the underlying causes of sexual dissatisfaction among women and expose how global drug companies exploit those problems in an attempt to create the next billion dollar disease.

Product Details

ISBN-13: 9781553655084
Publisher: Greystone Books
Publication date: 10/01/2010
Pages: 272
Product dimensions: 5.50(w) x 8.40(h) x 0.70(d)

About the Author

Ray Moynihan has been covering the business of health care for more than a decade with the Australian Broadcasting Corporation, the Australian Financial Review, and the British Medical Journal. He is an award-winning journalist and the author of three previous books, including Selling Sickness, which has been translated into a dozen languages.

Dr. Barbara Mintzes investigates the link between clinical trial and pharmacosurveillance evidence on drug safety and effectiveness, and provincial drug financing decisions. She holds a BA in geography from Simon Fraser University and a PhD in health care and epidemiology from UBC. She currently works at UBC in Vancouver as Assistant Professor in the Department of Pharmacology & Therapeutics.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews